
Gilgamesh Pharmaceuticals
Gilgamesh Pharmaceuticals is a YC Summer 2020 (S20) company. Based in New York, NY, USA; Remote. Team of 15.
About Gilgamesh Pharmaceuticals
Summary
Gilgamesh Pharmaceuticals develops novel chemical entities for mental health conditions, advancing candidates through clinical-stage trials. The company combines medicinal chemistry, neuroscience, and drug development to create proprietary psychedelic-derived therapeutics. This work replaces reliance on legacy psychiatric drugs with purpose-built molecules designed from the ground up for mental health indications.
From the Y Combinator listing
Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company…
Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.
Facts
- Healthcare / Healthcare -> Drug Discovery and Delivery
- New York, NY, USA; Remote
- 15
- Active
- Early
Founders (3)
- Andrew Kruegel
- Dalibor Sames
- JONATHAN SPORN
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works